High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor β receptor type II

Archives of Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 6, 2001, Pages 683-686

  Dillard, D G ^a   Muller, S ^a   Cohen, C ^a   Bloch, D ^a   Del Gaudio, J M ^a   Gal, A A ^a  

^a Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; PROTEIN SECRETION; SALIVARY GLAND CARCINOMA;

EID: 0034905373     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.127.6.683     Document Type: Article

References (19)

1. Incidence rates of salivary gland tumors: Results from a population-based study
2. Mucoepidermoid carcinoma of salivary glands: A clinicopathologic study of 367 cases
3. Mucoepidermoid carcinoma of the major salivary glands: Clinical and histopathologic analysis of 234 cases with evaluation of grading criteria
4. Histological features and prognosis of patients with mucoepidermoid carcinoma of the parotid gland
5. Biology of TGF-beta in knockout and transgenic mouse models
6. Regulation of monocyte and keratinocyte interleukin 6 production by transforming growth factor beta
7. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas
8. Neutralisation of TGF-beta1 and TGF-beta2 or exogenous addition of TGF-beta3 to cutaneous rat wounds reduces scarring
9. Natural inhibitor of transforming growth factor beta protects against scarring in experimental kidney disease
10. TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia
11. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells
12. Transforming growth factor-beta 1 induces apoptosis in gastric cancer cells through a p53-independent pathway
13. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland clones
14. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas
15. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells
16. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis
17. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2
18. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II levels of transforming growth factor beta receptor type II messenger RNA and protein
19. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients